2023 annual financial data
BriaCell Therapeutics 2023 Operating margin
BriaCell Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -23,272,264 USD and net income was -20,302,394 USD.
Operating cash flow was -23,744,860 USD.
Get free BriaCell Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -23,272,264 USD
- Net income
- -20,302,394 USD
- Operating cash flow
- -23,744,860 USD